Selecting the optimal tool for differential expression (DE) analysis is a critical decision in RNA-seq studies, directly impacting the biological insights gained.
De novo genome assembly is a critical first step in microbial genomics that significantly impacts downstream applications in drug development and clinical research.
This article provides a comprehensive framework for researchers and drug development professionals to design and execute robust validation of RNA-Seq data using qPCR.
This article provides a comprehensive guide for researchers and drug development professionals on correcting for multiple testing in high-throughput genomics experiments.
Bayesian phylogenetic analysis is a cornerstone of modern evolutionary biology, epidemiology, and drug development, yet it is frequently hampered by convergence issues in Markov Chain Monte Carlo (MCMC) sampling.
Poor alignment rates in RNA-Seq can compromise entire studies, leading to data loss and unreliable conclusions.
Low-abundance proteins are critical regulators in biology and promising biomarkers for disease, yet their analysis is hindered by the immense dynamic range of complex proteomes.
This article provides a comprehensive guide for researchers and drug development professionals on addressing the critical challenge of overfitting in machine learning models for genomics.
This article provides a detailed roadmap for researchers, scientists, and drug development professionals tackling the pervasive challenge of batch effects in microarray data.
This comprehensive guide addresses the critical challenge of parameter optimization in RNA-Seq differential expression analysis for researchers and drug development professionals.